• OUR DATA
  • BUY REPORTS & LISTS
  • OUR BLOG
 

JOHNSON & JOHNSON Revenue and Financial Data

It's difficult to get well without Johnson & Johnson (J&J). The diversified health care giant operates in three segments through more than 265 operating companies located in some 60 countries. Its Medical Devices division offers surgical equipment, monitoring devices, orthopedic products, and contact lenses, among other things. J&J's Pharmaceuticals division makes drugs for an array of ailments, such as neurological conditions, blood disorders, autoimmune diseases, and pain. Top sellers are psoriasis drug Remicade and cancer medication Velcade. Its Consumer business makes over-the-counter drugs and products for baby, skin, and oral care, as well as first-aid and nutritional uses.

Financials Information for JOHNSON & JOHNSON

Track this company’s financial condition.
View Company Report
Request Your Free Trial

  • Income Statement
  • Cash Flow
  • Balance Sheet
  • Credit Rating
Income Statement 2016 2014 2013 2012 2012
Revenue $70,074 $74,331 $71,312 $67,224 $65,030
Gross Profit $48,538 $51,585 $48,970 $45,566 $44,670
Operating Income $17,556 $20,959 $18,377 $15,869 $15,584
Net Income $15,409 $16,323 $13,831 $10,853 $9,672
Diluted EPS $5.48 $5.7 $4.81 $3.86 $3.49
Cash Flow (mil) 2016 2014 2013
Cash at the beginning of the year $ $20,927 $24,542
Net Operating Cash $19,279 $18,471 $17,414
Net Investing Cash $(7,735) $(12,305) $(5,103)
Net Financing Cash $(10,846) $(12,260) $(6,091)
Net Change in Cash $(791) $(6,404) $6,016
Cash at end of the year $13,732 $14,523 $20,927
Capital Expenditure $(3,463) $(3,714) $(3,595)
Assets (mil) 2016 2014 2013
Current Assets
Cash $13,732 $14,523 $20,927
Net Receivables $10,734 $10,985 $11,713
Inventories $8,053 $8,184 $7,878
Other Income Assets $3,047 $3,486 $4,003
Asset Summary
Total Current Assets $60,210 $59,311 $56,407
Net Fixed Assets $15,905 $16,126 $16,710
Other Noncurrent Assets $4,413 $3,232 $4,949
Total Assets $133,411 $131,119 $132,683
Liabilities (mil) 2016 2014 2013
Current Liabilities
Accounts Payable $6,668 $7,633 $6,266
Short Term Debt $7,004 $3,638 $4,852
Other Current Liabilities $0 $0 $0
Liability Summary
Total Current Liabilities $27,747 $25,085 $25,675
Long Term Debt $12,857 $15,122 $13,328
Other Noncurrent Liabilities $12,500 $10,298 $10,033
Total Liabilities $62,261 $61,367 $58,630
Stakeholder's Equity (mil) 2016 2014 2013
Equity
Preferred Stock Equity $ $ $
Common Stock Equity $3,120 $3,120 $3,120
Equity Summary
Total Equity $71,150 $69,752 $74,053
Shares Outstanding 2,755.1599 2,783.22 2,820.6299

Credit Rating

Low
These businesses have a low projected risk of delinquency and a moderate to low risk of failure.

Need to go deeper? No problem.

  • Save time with complex financial data at your fingertips
  • Access financial statements, SEC filings, earnings estimates, and more
  • Call (866) 473-3932 to talk to a Business Information Consultant